Companies:
49,943
Total Market Cap:
142461781987524.21
Global Rank
#33193
Country Rank
#108
Market Cap
32.21 M
Price
1.16
Change (%)
1.43%
Volume
8,015
Cessatech A/S's latest marketcap:
32.21 M
As of 07/26/2025, Cessatech A/S's market capitalization has reached $32.21 M. According to our data, Cessatech A/S is the 33193th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 32.21 M |
| Revenue (ttm) | 190,224.34 |
| Net Income (ttm) | -2,487,607.62 |
| Shares Out | 18.58 M |
| EPS (ttm) | -0.14 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/21/2025 |
Market Cap Chart
Data Updated: 07/26/2025
Cessatech A/S's yearly market capitalization.
Cessatech A/S has seen its market value grow from kr98.59 M to kr306.12 M since 2020, representing a total increase of 210.49% and an annual compound growth rate (CAGR) of 28.13%.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/26/2025 | kr306.12 M | $32.21 M | -5.82% | 33193 |
| 12/30/2024 | kr316.06 M | $28.41 M | 111.09% | 31826 |
| 12/29/2023 | kr149.72 M | $14.76 M | 348.92% | 35313 |
| 12/30/2022 | kr33.35 M | $3.18 M | -76.45% | 39394 |
| 12/30/2021 | kr141.63 M | $15.58 M | 43.65% | 33868 |
| 12/30/2020 | kr98.59 M | $11.93 M | 31522 |
Company Profile
About Cessatech A/S
Cessatech A/S is a pharmaceutical company specializing in the development and commercialization of medicines for pediatric acute pain. Headquartered in Copenhagen, Denmark, the company was founded in 2020.
Key Products
- CT001 – An analgesic nasal spray designed for acute and planned painful procedures in children.
- CT002 – A sedative nasal spray for children aged 0-17 undergoing medical procedures.
- CT003 – A local anesthetic gel for pain management.
Partnerships
Cessatech has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate innovative pain management therapies.
Frequently Asked Questions
-
What is Cessatech A/S's (NGM-CESSA) current market cap?As of 07/26/2025, Cessatech A/S (including the parent company, if applicable) has an estimated market capitalization of $32.21 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Cessatech A/S (NGM-CESSA) rank globally by market cap?Cessatech A/S global market capitalization ranking is approximately 33193 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.